These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 12324668

  • 21. Recombinant human DNase I in cystic fibrosis patients with severe pulmonary disease: a short-term, double-blind study followed by six months open-label treatment.
    Shah PI, Bush A, Canny GJ, Colin AA, Fuchs HJ, Geddes DM, Johnson CA, Light MC, Scott SF, Tullis DE.
    Eur Respir J; 1995 Jun; 8(6):954-8. PubMed ID: 7589382
    [Abstract] [Full Text] [Related]

  • 22. In vivo effects of recombinant human DNase I on sputum in patients with cystic fibrosis.
    Shah PL, Scott SF, Knight RA, Marriott C, Ranasinha C, Hodson ME.
    Thorax; 1996 Feb; 51(2):119-25. PubMed ID: 8711640
    [Abstract] [Full Text] [Related]

  • 23. [Effect of rhDNase on the respiratory function and nutritional status of children and adolescents with mucoviscidosis].
    Wizla-Derambure N, Michaud L, Sardet A, Deschildre A, Loeuille GA, Tassin E, Loire N, Buisine C, Boutry E, Dias J, Hecquet F, Turck D.
    Arch Pediatr; 1998 Apr; 5(4):378-83. PubMed ID: 9759156
    [Abstract] [Full Text] [Related]

  • 24. Mucoactive agents for chronic, non-cystic fibrosis lung disease: A systematic review and meta-analysis.
    Tarrant BJ, Le Maitre C, Romero L, Steward R, Button BM, Thompson BR, Holland AE.
    Respirology; 2017 Aug; 22(6):1084-1092. PubMed ID: 28397992
    [Abstract] [Full Text] [Related]

  • 25. Cystic fibrosis: cost of illness and considerations for the economic evaluation of potential therapies.
    Krauth C, Jalilvand N, Welte T, Busse R.
    Pharmacoeconomics; 2003 Aug; 21(14):1001-24. PubMed ID: 13129414
    [Abstract] [Full Text] [Related]

  • 26. Retrospective review of the effects of rhDNase in children with cystic fibrosis.
    Davies J, Trindade MT, Wallis C, Rosenthal M, Crawford O, Bush A.
    Pediatr Pulmonol; 1997 Apr; 23(4):243-8. PubMed ID: 9141109
    [Abstract] [Full Text] [Related]

  • 27. A randomised trial of hypertonic saline during hospitalisation for exacerbation of cystic fibrosis.
    Dentice RL, Elkins MR, Middleton PG, Bishop JR, Wark PA, Dorahy DJ, Harmer CJ, Hu H, Bye PT.
    Thorax; 2016 Feb; 71(2):141-7. PubMed ID: 26769016
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Aerosolized recombinant human DNase I for the treatment of cystic fibrosis.
    Shak S.
    Chest; 1995 Feb; 107(2 Suppl):65S-70S. PubMed ID: 7842816
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis.
    Ramsey BW, Astley SJ, Aitken ML, Burke W, Colin AA, Dorkin HL, Eisenberg JD, Gibson RL, Harwood IR, Schidlow DV.
    Am Rev Respir Dis; 1993 Jul; 148(1):145-51. PubMed ID: 8317790
    [Abstract] [Full Text] [Related]

  • 35. Dornase alfa for cystic fibrosis.
    Jones AP, Wallis C.
    Cochrane Database Syst Rev; 2010 Mar 17; (3):CD001127. PubMed ID: 20238314
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Comparing the efficacy of nebulizer recombinant human DNase and hypertonic saline as monotherapy and combined treatment in the treatment of persistent atelectasis in mechanically ventilated newborns.
    Altunhan H, Annagür A, Pekcan S, Ors R, Koç H.
    Pediatr Int; 2012 Feb 17; 54(1):131-6. PubMed ID: 22114907
    [Abstract] [Full Text] [Related]

  • 38. Airway inflammation after treatment with aerosolized deoxyribonuclease in cystic fibrosis.
    Henry RL, Gibson PG, Carty K, Cai Y, Francis JL.
    Pediatr Pulmonol; 1998 Aug 17; 26(2):97-100. PubMed ID: 9727759
    [Abstract] [Full Text] [Related]

  • 39. Effect of a short course of rhDNase on cough and mucociliary clearance in patients with cystic fibrosis.
    Robinson M, Hemming AL, Moriarty C, Eberl S, Bye PT.
    Pediatr Pulmonol; 2000 Jul 17; 30(1):16-24. PubMed ID: 10862158
    [Abstract] [Full Text] [Related]

  • 40. [Multicenter study of rhDNase in cystic fibrosis with severe pulmonary involvement].
    Hodson M.
    Arch Pediatr; 1995 Jul 17; 2(7):679-81. PubMed ID: 7663660
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.